News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Bio Pharma Reporter and Outsourcing Pharma is back with our latest instalment of movers and shakers - breaking down all the key pharma industry appointments that you should know about. KBI Biopharma, Veranova and Kindeva Drug Delivery are among the...
Outsourcing Pharma and BioPharma Reporter breaks down the key people on the move in the pharma industry. Enhanc3D Genomics, Cytomos and Cellular Origins are among the companies welcoming new faces to top jobs.
At Advanced Therapies Week 2024 in Miami, Isabel Cameron hosted a roundtable discussion to discuss all things cell and gene therapy manufacturing.
BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers, shakers and key announcements in the pharma industry. From Stand Up To Cancer, Astraveus and KBI Biopharma, we break down the key changes.
IO Biotech, Quotient Sciences and Terumo Blood and Cell Technologies are among the key companies welcoming new colleagues.
BioPharma Reporter and Outsourcing Pharma is keeping you in the know with our most recent round-up of important appointments in the pharma industry - including Veranova, Matica Bio and Aldevron.
BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers and shakers in the pharma industry. From Karuna Therapeutics to IO Biotech, we break down the key changes on the pharmaceutical job ladder.
Biopharma-Reporter takes you inside the recently opened Testa BioProcess Innovation Center in Uppsala, Sweden, and speaks with CEO of GE Nordics, Lotta Ljungqvist.
NIBRT is embracing continuous bioprocessing says training director John Milne, who told us the method helps improve plant flexibility and could reduce manufacturing costs.
GE Healthcare opened its European Innovative Design and Advanced Manufacturing Technology Center last month. Biopharma-Reporter took a visit to Uppsala, Sweden to find out more.
Campaigning group People for the Ethical Treatment of Animals (PETA) picketed a conference in Boston on Tuesday to protest the use of animals in drug research and development.
BPI EUROPE 2017
Pall Corporation, GE Healthcare and LEWA Process Technologies showed off their latest downstream offerings to Biopharma-Reporter in Amsterdam last week.
DISPATCHES FROM BPI EUROPE 2017
Hands-on teaching offers drugmakers, vendors and regulators a better understanding of bioprocessing, according to the managing director of a training facility in Leiden, The Netherlands.
BPI Europe 2016
Pall Corporation has embraced a virtual reality platform to showcase some of its bioprocessing systems at industry shows.
With Pfizer closing in on Hospira and Sandoz set to launch Zarxio in the US, it’s been a defining week for biosimilars, our BioFinance Vision feature explains.
We say hello to Baxalta, ask what's the latest in Danaher's $14bn bid for Pall, and look at the latest biotech IPOs in today's Bio-Finance Vision.
DISPATCHES FROM BPI 2015
GE Healthcare has embraced Xbox Kinect technology to virtually demonstrate its upstream and downstream offerings at tradeshows.
Festive Film
The holidays are fast upon us, so let’s put ‘business’ to one side and get into the festive mood. To keep in the spirit of things, we’ve got a ‘gift’ for you – enjoy. Happy Holidays!
Dispatches from interphex
Aenova says the acquisition of Haupt Pharma and Patheon’s merger with DSM are evidence of consolidation in the CMO industry, as it looks to further increase its global footprint.
News from Interphex 2014
Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.
DISPATCHES FROM INTERPHEX
While there will always be space for stainless steel systems, single-use technology is now mainstream according to Pall and ATMI.
DISPATCHES FROM INTERPHEX
Patheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.
DISPATCHES FROM INTERPHEX 2014
‘Podular’ manufacturing systems will dominate facility design within five years, say G-CON and GEA who have teamed with Pfizer to create a flexible, repurposable and portable facility.
DISPATCHES FROM INTERPHEX
The thorny issue of applying QbD to biopharmaceutical manufacture is a topic of hot debate at Interphex 2014 according to CMO Cook Pharmica.
When Frank Sinatra sang "If you can make it there, you can make it anywhere" in New York, New York he probably wasn't talking about biopharmaceutical production.
DISPATCHES FROM INTERPHEX
Over the last decade single-use technologies have moved into manufacturing scales and are increasingly being deployed worldwide, according to Thermo Fisher Scientific.
LIVE FROM INTERPHEX
Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the issues affecting the biotech industry today, according to experts at this year’s Interphex.
ATMI has added helium integrity testing of bioprocess vessels in response to what it says is a boom in the single-use technology arena.
EMD Millipore premiered a new single-use bioreactor at Interphex 2012, claiming the new design addresses industry demand for ease of use and flexibility.
Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.
Covance is adding mass spectrometry and other capabilities to meet growing demand for biosimilar comparability services.
SAFC will extend its focus on high potency production through a number of new investments.
How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.
Recognition of glass vial quality issues is supporting interest in West’s analytical capabilities and Crystal Zenith (CZ) products, new sizes of which are being developed, said a company VP.
Icon is adding protein and peptide profiling to its biomarker capabilities through a strategic alliance with Proteome Sciences.
SAFC has completed the expansion of its manufacturing plant in Jerusalem, Israel, further increasing its global footprint.
US supplier SAFC recently expanded its liquid cell culture reagents in response to growing biomanufacturing industry demand.
Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.